Ardelyx (ARDX) Capital Expenditures Growth (1y) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 227.76% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | 0.57% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 143.40% |
| 10 | Ardelyx | 1.48 Bn | 1.25 Bn | 89.66 Mn | -78.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -78.77% |
| Dec 31, 2025 | -39.12% |
| Sep 30, 2025 | 13.87% |
| Jun 30, 2025 | 396.18% |
| Mar 31, 2025 | 116.67% |
| Dec 31, 2024 | 1,279.07% |
| Sep 30, 2024 | -29.38% |
| Jun 30, 2024 | 40.86% |
| Mar 31, 2024 | 971.43% |
| Dec 31, 2023 | -21.82% |
| Dec 31, 2022 | 157.89% |
| Dec 31, 2021 | -138.00% |
| Sep 30, 2021 | 808.16% |
| Mar 31, 2021 | 3,012.00% |
| Sep 30, 2020 | -57.02% |
| Mar 31, 2020 | -84.85% |
| Sep 30, 2019 | 467.74% |
| Mar 31, 2019 | 200.00% |
| Dec 31, 2018 | 925.00% |
| Sep 30, 2018 | -107.38% |
| Mar 31, 2018 | -95.08% |
| Dec 31, 2017 | -98.98% |
| Sep 30, 2017 | -73.96% |
| Jun 30, 2017 | 167.46% |
| Mar 31, 2017 | 459.00% |
| Dec 31, 2016 | 507.49% |
| Sep 30, 2016 | -43.72% |
| Jun 30, 2016 | 395.00% |
| Mar 31, 2016 | -14.53% |
| Dec 31, 2015 | -56.01% |
| Sep 30, 2015 | 3,156.82% |
| Jun 30, 2015 | -115.58% |
| Mar 31, 2015 | 148.94% |
| Dec 31, 2014 | 471.22% |
| Sep 30, 2014 | 319.05% |